Cite
HARVARD Citation
Fujinaga, S. et al. (2020). Efficacy of the novel selective β3‐adrenoreceptor agonist vibegron for treatment‐resistant monosymptomatic nocturnal enuresis in children. International journal of urology. pp. 693-694. [Online].